Home › Endocrine Diseases › Texas › Houston
Endocrine Diseases clinical trials in Houston, TX
6 studies for Endocrine Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RecruitingPhase 3
- Ascendis Pharma Investigational Site, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
- Site-106, Houston
- Site-101, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
Rare and Atypical Diabetes Network
RecruitingObservational study
- Baylor College of Medicine, Houston
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
RecruitingObservational study
- University of Texas MD Anderson Cancer Center, Houston
About Endocrine Diseases
The Endocrine system has eight major glands that make hormones. Diabetes is the most common endocrine disease in the USA.
More about Endocrine Diseases on MedlinePlus
Endocrine Diseases trials in other cities
- Washington, DC5 studies
- Chicago, IL4 studies
- Miami, FL3 studies
- San Antonio, TX3 studies
- Seattle, WA3 studies
- Boston, MA3 studies
- New York City, NY3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.